持续十二指肠左旋多巴-卡比多巴输注（Duodopa）的长期经验：6例患者的报告。 - Suppr

Suppr

超能文献

Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.

作者信息

Raudino F, Garavaglia P, Pianezzola C, Riboldazzi G, Leva S, Guidotti M, Bono G

出版信息

Neurol Sci. 2009 Feb;30(1):85-6. doi: 10.1007/s10072-009-0022-1. Epub 2009 Jan 24.

DOI:10.1007/s10072-009-0022-1

PMID:19169622

Abstract

摘要

相似文献

Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.

Neurol Sci. 2009 Feb;30(1):85-6. doi: 10.1007/s10072-009-0022-1. Epub 2009 Jan 24.

[Levodopa intestinal infusion therapy in Parkinson's disease].

Neurol Neurochir Pol. 2010 Jul-Aug;44(4):396-403. doi: 10.1016/s0028-3843(14)60299-1.

Knotting of Duodopa® duodenal infusion system.

Rev Esp Enferm Dig. 2015 May;107(5):323-4.

A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.

Clin Neuropharmacol. 2011 Mar-Apr;34(2):61-5. doi: 10.1097/WNF.0b013e31820b570a.

Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.

J Neurol. 2013 Jan;260(1):105-14. doi: 10.1007/s00415-012-6597-0. Epub 2012 Jul 8.

[Continuous treatment with levodopa of Parkinson disease].

Tidsskr Nor Laegeforen. 2005 Oct 6;125(19):2638-40.

Duodenal levodopa infusion in Parkinson's disease--long-term experience.

Acta Neurol Scand. 2001 Dec;104(6):343-8. doi: 10.1034/j.1600-0404.2001.00153.x.

Continuous dopaminergic stimulation achieved by duodenal levodopa infusion.

Neurol Sci. 2008 Dec;29 Suppl 5:S387-8. doi: 10.1007/s10072-008-1054-7.

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

Neurology. 2005 Jan 25;64(2):216-23. doi: 10.1212/01.WNL.0000149637.70961.4C.

Continuous duodenal infusions of levodopa.

J Neurosci Nurs. 1993 Oct;25(5):317-20. doi: 10.1097/01376517-199310000-00009.

引用本文的文献

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

eNeurologicalSci. 2017 Jul 2;8:44-53. doi: 10.1016/j.ensci.2017.06.004. eCollection 2017 Sep.

Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.

Brain Behav. 2017 Jul 7;7(8):e00758. doi: 10.1002/brb3.758. eCollection 2017 Aug.

Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.

J Neural Transm (Vienna). 2013 Nov;120(11):1553-8. doi: 10.1007/s00702-013-1026-9. Epub 2013 Apr 18.

PINK1: pumps, paraesthesia, punding and psychosis.

J Neurol. 2012 Jun;259(6):1241-2. doi: 10.1007/s00415-011-6327-z. Epub 2011 Nov 30.

本文引用的文献

Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.

Neurodegener Dis. 2008;5(3-4):244-6. doi: 10.1159/000113714. Epub 2008 Mar 6.

Duodenal levodopa infusion for the treatment of Parkinson's disease.

Expert Opin Pharmacother. 2007 Apr;8(5):657-64. doi: 10.1517/14656566.8.5.657.

Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.

Expert Rev Neurother. 2006 Oct;6(10):1403-11. doi: 10.1586/14737175.6.10.1403.

Dopamine dysregulation syndrome in Parkinson's disease.

Curr Opin Neurol. 2004 Aug;17(4):393-8. doi: 10.1097/01.wco.0000137528.23126.41.

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Mov Disord. 1999 Jul;14(4):572-84. doi: 10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Long-term experience with continuous duodenal levodopa-carbidopa infusion (Duodopa): report of six patients.

Neurol Sci. 2009 Feb;30(1):85-6. doi: 10.1007/s10072-009-0022-1. Epub 2009 Jan 24.

[Levodopa intestinal infusion therapy in Parkinson's disease].

Neurol Neurochir Pol. 2010 Jul-Aug;44(4):396-403. doi: 10.1016/s0028-3843(14)60299-1.

Knotting of Duodopa® duodenal infusion system.

Rev Esp Enferm Dig. 2015 May;107(5):323-4.

A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.

Clin Neuropharmacol. 2011 Mar-Apr;34(2):61-5. doi: 10.1097/WNF.0b013e31820b570a.

Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.

J Neurol. 2013 Jan;260(1):105-14. doi: 10.1007/s00415-012-6597-0. Epub 2012 Jul 8.

[Continuous treatment with levodopa of Parkinson disease].

Tidsskr Nor Laegeforen. 2005 Oct 6;125(19):2638-40.

Duodenal levodopa infusion in Parkinson's disease--long-term experience.

Acta Neurol Scand. 2001 Dec;104(6):343-8. doi: 10.1034/j.1600-0404.2001.00153.x.

Continuous dopaminergic stimulation achieved by duodenal levodopa infusion.

Neurol Sci. 2008 Dec;29 Suppl 5:S387-8. doi: 10.1007/s10072-008-1054-7.

Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.

Neurology. 2005 Jan 25;64(2):216-23. doi: 10.1212/01.WNL.0000149637.70961.4C.

Continuous duodenal infusions of levodopa.

J Neurosci Nurs. 1993 Oct;25(5):317-20. doi: 10.1097/01376517-199310000-00009.

引用本文的文献

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

eNeurologicalSci. 2017 Jul 2;8:44-53. doi: 10.1016/j.ensci.2017.06.004. eCollection 2017 Sep.

Long-term safety and effectiveness of levodopa-carbidopa intestinal gel infusion.

Brain Behav. 2017 Jul 7;7(8):e00758. doi: 10.1002/brb3.758. eCollection 2017 Aug.

Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.

J Neural Transm (Vienna). 2013 Nov;120(11):1553-8. doi: 10.1007/s00702-013-1026-9. Epub 2013 Apr 18.

PINK1: pumps, paraesthesia, punding and psychosis.

J Neurol. 2012 Jun;259(6):1241-2. doi: 10.1007/s00415-011-6327-z. Epub 2011 Nov 30.

本文引用的文献

Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.

Neurodegener Dis. 2008;5(3-4):244-6. doi: 10.1159/000113714. Epub 2008 Mar 6.

Duodenal levodopa infusion for the treatment of Parkinson's disease.

Expert Opin Pharmacother. 2007 Apr;8(5):657-64. doi: 10.1517/14656566.8.5.657.

Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.

Expert Rev Neurother. 2006 Oct;6(10):1403-11. doi: 10.1586/14737175.6.10.1403.

Dopamine dysregulation syndrome in Parkinson's disease.

Curr Opin Neurol. 2004 Aug;17(4):393-8. doi: 10.1097/01.wco.0000137528.23126.41.

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Mov Disord. 1999 Jul;14(4):572-84. doi: 10.1002/1531-8257(199907)14:4<572::aid-mds1005>3.0.co;2-c.